Loading...

We've got a brand new version of Simply Wall St! Try it out

Golden Leaf Holdings

CNSX:GLH
Snowflake Description

Imperfect balance sheet and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
GLH
CNSX
CA$30M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

Golden Leaf Holdings Ltd., through its subsidiaries, produces, distributes, and sells cannabis oil and flower products. The last earnings update was 25 days ago. More info.


Add to Portfolio Compare Print
  • Golden Leaf Holdings has significant price volatility in the past 3 months.
GLH Share Price and Events
7 Day Returns
0%
CNSX:GLH
-0.2%
CA Pharmaceuticals
1.2%
CA Market
1 Year Returns
-85.1%
CNSX:GLH
-45.8%
CA Pharmaceuticals
-0.4%
CA Market
GLH Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Golden Leaf Holdings (GLH) 0% -30% -50% -85.1% -90.5% -
CA Pharmaceuticals -0.2% -1.8% -21.5% -45.8% 251% 334.4%
CA Market 1.2% 3.3% 0.8% -0.4% 7.4% 4.5%
1 Year Return vs Industry and Market
  • GLH underperformed the Pharmaceuticals industry which returned -45.8% over the past year.
  • GLH underperformed the Market in Canada which returned -0.4% over the past year.
Price Volatility
GLH
Industry
5yr Volatility vs Market

GLH Value

 Is Golden Leaf Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Golden Leaf Holdings. This is due to cash flow or dividend data being unavailable. The share price is CA$0.035.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Golden Leaf Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Golden Leaf Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:GLH PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $-0.04
CNSX:GLH Share Price ** CNSX (2019-09-19) in CAD CA$0.04
CNSX:GLH Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.03
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 18.72x
Canada Market PE Ratio Median Figure of 540 Publicly-Listed Companies 14.11x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Golden Leaf Holdings.

CNSX:GLH PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:GLH Share Price ÷ EPS (both in USD)

= 0.03 ÷ -0.04

-0.69x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Golden Leaf Holdings is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Golden Leaf Holdings is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Golden Leaf Holdings's expected growth come at a high price?
Raw Data
CNSX:GLH PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.69x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.57x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Golden Leaf Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Golden Leaf Holdings's assets?
Raw Data
CNSX:GLH PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $0.07
CNSX:GLH Share Price * CNSX (2019-09-19) in CAD CA$0.04
CNSX:GLH Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.03
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.32x
Canada Market PB Ratio Median Figure of 2,454 Publicly-Listed Companies 1.44x
CNSX:GLH PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:GLH Share Price ÷ Book Value per Share (both in USD)

= 0.03 ÷ 0.07

0.39x

* Primary Listing of Golden Leaf Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Golden Leaf Holdings is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Golden Leaf Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Golden Leaf Holdings has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

GLH Future Performance

 How is Golden Leaf Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Golden Leaf Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
110.6%
Expected Pharmaceuticals industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Golden Leaf Holdings expected to grow at an attractive rate?
  • Unable to compare Golden Leaf Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Golden Leaf Holdings's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare Golden Leaf Holdings's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:GLH Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 110.6%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 58.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:GLH Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:GLH Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2019-09-20
CNSX:GLH Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 18 -15 -22
2019-03-31 18 -17 -16
2018-12-31 16 -17 -5
2018-09-30 16 -22 -43
2018-06-30 14 -21 -41
2018-03-31 12 -17 -46
2017-12-31 12 -16 -56
2017-09-30 8 -9 -25
2017-06-30 7 -8 -24
2017-03-31 8 -10 -23
2016-12-31 8 -9 -21
2016-09-30 10 -5 -4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Golden Leaf Holdings is high growth as no earnings estimate data is available.
  • Unable to determine if Golden Leaf Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:GLH Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Golden Leaf Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:GLH Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2019-09-20
CNSX:GLH Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 -0.04
2019-03-31 -0.03
2018-12-31 -0.01
2018-09-30 -0.08
2018-06-30 -0.09
2018-03-31 -0.13
2017-12-31 -0.22
2017-09-30 -0.14
2017-06-30 -0.21
2017-03-31 -0.22
2016-12-31 -0.23
2016-09-30 -0.05

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Golden Leaf Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Golden Leaf Holdings's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Pharmaceuticals & Biotech companies here
  2. Golden Leaf Holdings's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Golden Leaf Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Golden Leaf Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

GLH Past Performance

  How has Golden Leaf Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Golden Leaf Holdings's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Golden Leaf Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Golden Leaf Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Golden Leaf Holdings's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Golden Leaf Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Golden Leaf Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:GLH Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 18.16 -22.43 19.64
2019-03-31 17.53 -15.75 21.88
2018-12-31 16.45 -4.57 21.21
2018-09-30 16.03 -43.43 14.10
2018-06-30 14.04 -41.10 14.24
2018-03-31 12.45 -46.06 11.56
2017-12-31 11.51 -56.48 10.48
2017-09-30 7.93 -24.67 11.43 0.02
2017-06-30 7.23 -23.88 8.18 0.19
2017-03-31 7.60 -23.25 8.97 0.06
2016-12-31 7.66 -21.33 9.60 0.19
2016-09-30 10.08 -3.50 10.65 0.26
2016-06-30 10.42 -5.39 13.51 0.27
2016-03-31 10.92 -7.73 13.84 0.51
2015-12-31 9.93 -17.46 12.50 0.46
2015-09-30 8.51 -20.42 12.05 0.40
2014-12-31 1.75 -4.27 4.34 0.03

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Golden Leaf Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Golden Leaf Holdings has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Golden Leaf Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Golden Leaf Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Golden Leaf Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

GLH Health

 How is Golden Leaf Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Golden Leaf Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Golden Leaf Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Golden Leaf Holdings's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Golden Leaf Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Golden Leaf Holdings Company Filings, last reported 2 months ago.

CNSX:GLH Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 39.63 14.53 5.25
2019-03-31 43.06 14.27 8.29
2018-12-31 46.59 14.27 12.28
2018-09-30 54.43 12.05 12.34
2018-06-30 59.16 12.43 15.70
2018-03-31 53.28 17.61 22.14
2017-12-31 17.34 31.23 6.01
2017-09-30 47.45 6.07 0.63
2017-06-30 6.46 12.91 0.10
2017-03-31 2.59 17.58 0.46
2016-12-31 -2.94 25.55 3.94
2016-09-30 8.07 11.58 0.24
2016-06-30 9.82 10.90 0.23
2016-03-31 10.79 8.48 0.91
2015-12-31 -1.71 3.83 0.26
2015-09-30 -3.41 3.89 1.13
2014-12-31 1.81 0.09 0.60
  • Golden Leaf Holdings's level of debt (36.7%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Golden Leaf Holdings's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Golden Leaf Holdings has less than a year of cash runway based on current free cash flow.
  • Golden Leaf Holdings has less than a year of cash runway if free cash flow continues to grow at historical rates of 30.7% each year.
X
Financial health checks
We assess Golden Leaf Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Golden Leaf Holdings has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

GLH Dividends

 What is Golden Leaf Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Golden Leaf Holdings dividends.
If you bought CA$2,000 of Golden Leaf Holdings shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Golden Leaf Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Golden Leaf Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:GLH Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

CNSX:GLH Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2019-09-20

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Golden Leaf Holdings has not reported any payouts.
  • Unable to verify if Golden Leaf Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Golden Leaf Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Golden Leaf Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Golden Leaf Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Golden Leaf Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Golden Leaf Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

GLH Management

 What is the CEO of Golden Leaf Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jeff Yapp
AGE 60
TENURE AS CEO 0.7 years
CEO Bio

Mr. Jeffrey B. Yapp, also known as Jeff, serves as Chief Executive Officer and Director at Golden Leaf Holdings Ltd. since 2019 and had been its Chief Marketing and Sales Officer since September 06, 2018. In this role, Mr. Yapp was responsible for setting Golden Leaf’s global retail and franchising strategy, and overseeing the Company’s wholesale revenue, marketing and public relations initiatives. Mr. Yapp joins Golden Leaf Holdings with many years of experience working as a visionary and creative leader in the consumer and technology space, helping brands such as Microsoft, MTV, Cabelvision, Hollywood Entertainment, Twentieth Century Fox and Pepsico achieve their creative vision and make a multi-national impact. Prior to joining Golden Leaf, Mr. Yapp was most recently the founder and CEO of Wutznxt, a strategic marketing and consulting firm that works with and advises startups, as well as well-known brands like Microsoft and VICE, a Next Generation Media Company. In his role, Mr. Yapp was integral in supporting new product launches, helping to guide international retail expansion and building out new brand initiatives. He is a Founder of NXTM LLC and serves as its Chief Executive Officer. Mr. Yapp serves as President of Hollywood Entertainment Corp. Prior to joining Hollywood Entertainment Corp., Mr. Yapp served as President Worldwide of Twentieth Century Fox Home Entertainment, Inc. and as President of Fox International. He served as the Chairman of Legend3D, Inc. (formerly, Legend Films, Inc). He has been Director of American Film Technologies, Inc. since July 5, 2000. He serves as a Director of NXTM LLC. He holds MBA from Kellogg School at northwestern and undergraduate from University of Michigan.

CEO Compensation
  • Insufficient data for Jeff to compare compensation growth.
  • Insufficient data for Jeff to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure of the Golden Leaf Holdings management team in years:

0.7
Average Tenure
  • The average tenure for the Golden Leaf Holdings management team is less than 2 years, this suggests a new team.
Management Team

John Varghese

TITLE
Executive Chairman
COMPENSATION
$80K
AGE
53
TENURE
0.7 yrs

William Simpson

TITLE
Founder & Board Observer
COMPENSATION
$299K

Mike Genovese

TITLE
Chief Operating Officer
COMPENSATION
$256K
TENURE
2.2 yrs

Jeff Yapp

TITLE
CEO & Director
AGE
60
TENURE
0.7 yrs

Jason Benedict

TITLE
Controller & Interim CFO
TENURE
0.3 yrs

John Magliana

TITLE
Corporate General Counsel

Kate Koustareva

TITLE
Director of Financial Reporting & Treasury

Brian Gentry

TITLE
Financial Consultant
COMPENSATION
$215K
TENURE
3.1 yrs
Board of Directors Tenure

Average tenure and age of the Golden Leaf Holdings board of directors in years:

0.7
Average Tenure
60
Average Age
  • The average tenure for the Golden Leaf Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

John Varghese

TITLE
Executive Chairman
COMPENSATION
$80K
AGE
53
TENURE
0.7 yrs

William Simpson

TITLE
Founder & Board Observer
COMPENSATION
$299K
TENURE
0.8 yrs

Jeff Yapp

TITLE
CEO & Director
AGE
60
TENURE
0.7 yrs

Alex Winch

TITLE
Director
TENURE
2.9 yrs

Bob McKnight

TITLE
Director
AGE
64
TENURE
2.3 yrs

Larry Martin

TITLE
Director
TENURE
0.7 yrs

Rick Miller

TITLE
Lead Director
TENURE
0.7 yrs

Peter Saladino

TITLE
Director
TENURE
3.5 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Golden Leaf Holdings individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
03. Sep 19 Buy Jeffrey Yapp Individual 03. Sep 19 03. Sep 19 26,861,622 CA$0.06 CA$1,611,695
03. Sep 19 Buy John Varghese Individual 03. Sep 19 03. Sep 19 26,861,622 CA$0.06 CA$1,611,695
29. Aug 19 Buy Alexander Winch Individual 29. Aug 19 29. Aug 19 800,000 CA$0.04 CA$32,000
19. Jul 19 Sell Phillip Millar Individual 06. May 19 17. Jul 19 -3,314,339 CA$0.11 CA$-247,571
17. Jul 19 Sell Phillip Millar Individual 10. Jul 19 15. Jul 19 -4,420,000 CA$0.06 CA$-249,631
X
Management checks
We assess Golden Leaf Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Golden Leaf Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

GLH News

Simply Wall St News

Who Owns Most Of Golden Leaf Holdings Ltd (CNSX:GLH)?

I am going to take a deep dive into Golden Leaf Holdings Ltd’s (CNSX:GLH) most recent ownership structure, not a frequent subject of discussion among individual investors. … View our latest analysis for Golden Leaf Holdings … CNSX:GLH Ownership Summary August 30th 18

Simply Wall St -

GLH Company Info

Description

Golden Leaf Holdings Ltd., through its subsidiaries, produces, distributes, and sells cannabis oil and flower products. It offers its products under the Private Stash, Golden, Jackpot, Chalice, Elysium Fields, Medical Marijuana Consulting, and Medical Marijuana Group brands. The company also engages in the leasing of real estate property; ownership and leasing of capital equipment; and medical marijuana patient consulting activities. In addition, it operates a network of six dispensaries under the Chalice Farms brand; and one dispensary under the Left Coast Connections brand in Oregon. Golden Leaf Holdings Ltd. was incorporated in 2014 and is headquartered in Toronto, Canada.

Details
Name: Golden Leaf Holdings Ltd.
GLH
Exchange: CNSX
Founded: 2014
CA$30,446,112
869,888,938
Website: http://goldenleafholdings.com
Address: Golden Leaf Holdings Ltd.
95 Richmond Street East,
Toronto,
Ontario, M5C 2C5,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX GLH Common Shares Canadian National Stock Exchange CA CAD 23. Oct 2015
OTCPK GLDF.F Common Shares Pink Sheets LLC US USD 23. Oct 2015
DB 9GL Common Shares Deutsche Boerse AG DE EUR 23. Oct 2015
Number of employees
Current staff
Staff numbers
149
Golden Leaf Holdings employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/20 01:18
End of day share price update: 2019/09/19 00:00
Last estimates confirmation: 2019/06/03
Last earnings filing: 2019/08/26
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.